TLRY - Tilray, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Tilray, Inc.

1100 Maughan Road
Nanaimo, BC V9X IJ2

IndustryDrug Manufacturers—Specialty & Generic
Full-time employees1,646

Key executives

NameTitlePayExercisedYear born
Mr. Brendan KennedyChairman & CEO592.15k6.35M1972
Mr. Andrew PucherChief Corp. Devel. Officer253.99kN/A1983
Mr. Edward Wood Pastorius Jr.Chief Revenue Officer3.11M2.43M1968
Ms. Kathryn P. DicksonPres of Manitoba Harvest USA, LLC130.23kN/A1965
Mr. Michael C. KruteckChief Financial OfficerN/AN/A1962
Amounts are as of 31 December 2019, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products to patients, physicians, pharmacies, governments, and hospitals; and for researchers for commercial purposes, and compassionate access and clinical research applications. It operates in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, the United Kingdom, the United States, and South Africa. The company was incorporated in 2018 and is headquartered in Nanaimo, Canada.

Corporate governance

Tilray, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.